https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-82007-11-01 00:00:002019-02-15 08:39:22Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Gan To Kagaku Ryoho 2007 Nov;34(12):1905-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Gan To Kagaku Ryoho 2007 Nov;34(12):1905-72007-11-01 00:00:002019-02-15 08:44:36[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-72007-11-01 00:00:002019-02-15 08:46:53[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-19
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-192007-11-01 00:00:002020-06-23 09:32:35Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-242007-11-01 00:00:002019-02-15 08:51:00Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-19 / Cell Death Differ. 2008 Jan;15(1):58-69
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-19 / Cell Death Differ. 2008 Jan;15(1):58-692007-10-19 00:00:002019-02-15 08:44:36The ‚kiss of death‘ by dendritic cells to cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-17 / Clin. Vaccine Immunol. 2008 Feb;15(2):284-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-17 / Clin. Vaccine Immunol. 2008 Feb;15(2):284-922007-10-17 00:00:002019-02-15 09:15:07Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-15 / Cancer 2007 Oct;110(8):1677-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-15 / Cancer 2007 Oct;110(8):1677-862007-10-15 00:00:002007-10-15 00:00:00Breast cancer vaccines: promise for the future or pipe dream?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-09 / Mol. Ther. 2008 Jan;16(1):210-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-09 / Mol. Ther. 2008 Jan;16(1):210-72007-10-09 00:00:002019-02-15 08:37:36Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-10-09 / Br. J. Cancer 2007 Nov;97(9):1251-92007-10-09 00:00:002019-02-15 08:50:17Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
